Search Results - Perkovic, V.
- Showing 1 - 13 results of 13
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: a meta-analysis of randomised trials. by Blood Pressure Lowering Treatment Trialists' Collaboration, Ying, A., Arima, H., Czernichow, S., Woodward, M., Huxley, Rachel, Turnbull, F., Perkovic, V., Neal, B.
Published 2015Get full text
-
8
-
9
-
10
Isolated low levels of high-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease: An individual participant data meta-analysis of 23 stud... by Huxley, Rachel, Barzi, F., Lam, T., Czernichow, S., Fang, X., Welborn, T., Shaw, J., Ueshima, H., Zimmet, P., Jee, S., Patel, J., Caterson, I., Perkovic, V., Woodward, M.
Published 2011Get full text
-
11
Blood pressure is a major risk factor for renal death: An analysis of 560 352 participants from the asia-pacific region by O'Seaghdha, C., Perkovic, V., Lam, T., McGinn, S., Barzi, F., Gu, D., Cass, A., Suh, I., Muntner, P., Giles, G., Ueshima, H., Woodward, M., Huxley, Rachel
Published 2009Get full text
-
12
The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: Meta-analysis of rand... by Czernichow, S., Zanchetti, A., Turnbull, F., Barzi, F., Ninomiya, T., Kengne, A., Lambers Heerspink, H., Perkovic, V., Huxley, Rachel, Arima, H., Patel, A., Chalmers, J., Woodward, M., MacMahon, S., Neal, B.
Published 2011Get full text
-
13
Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial by Gummer, J., Trengove, R., Pascoe, E., Badve, S., Cass, A., Clarke, P., McDonald, S., Morrish, A., Pedagogos, E., Perkovic, V., Reidlinger, D., Scaria, A., Walker, R., Vergara, L., Hawley, C., Johnson, D., Olynyk, John, Ferrari, P.
Published 2017Get full text